[go: up one dir, main page]

WO2009036753A3 - Neue pharmazeutika, verfahren zu ihrer herstellung und ihre verwendung in der medizinischen therapie - Google Patents

Neue pharmazeutika, verfahren zu ihrer herstellung und ihre verwendung in der medizinischen therapie Download PDF

Info

Publication number
WO2009036753A3
WO2009036753A3 PCT/DE2008/001566 DE2008001566W WO2009036753A3 WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3 DE 2008001566 W DE2008001566 W DE 2008001566W WO 2009036753 A3 WO2009036753 A3 WO 2009036753A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
medical therapy
novel pharmaceuticals
novel
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2008/001566
Other languages
English (en)
French (fr)
Other versions
WO2009036753A2 (de
Inventor
Hans Scheefers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ScheBo Biotech AG
Original Assignee
ScheBo Biotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ScheBo Biotech AG filed Critical ScheBo Biotech AG
Publication of WO2009036753A2 publication Critical patent/WO2009036753A2/de
Publication of WO2009036753A3 publication Critical patent/WO2009036753A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die vorliegende Patentanmeldung betrifft neue Pharmazeutika auf der Basis neuartig substituierter 4-Pyridin-3yl-pyrimidine, Verfahren zu Ihrer Herstellung und ihre Verwendung in der medizinischen Therapie, insbesondere bei Krebserkrankungen.
PCT/DE2008/001566 2007-09-20 2008-09-19 Neue pharmazeutika, verfahren zu ihrer herstellung und ihre verwendung in der medizinischen therapie Ceased WO2009036753A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007046266.4 2007-09-20
DE102007046266 2007-09-20

Publications (2)

Publication Number Publication Date
WO2009036753A2 WO2009036753A2 (de) 2009-03-26
WO2009036753A3 true WO2009036753A3 (de) 2009-05-07

Family

ID=40379649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/001566 Ceased WO2009036753A2 (de) 2007-09-20 2008-09-19 Neue pharmazeutika, verfahren zu ihrer herstellung und ihre verwendung in der medizinischen therapie

Country Status (1)

Country Link
WO (1) WO2009036753A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019852A1 (de) 2009-05-06 2010-11-11 Schebo Biotech Ag Polymere mit neuen Strukturelementen, Verfahren zu ihrer Herstellung und ihre Verwendung

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (en) * 2003-12-19 2005-06-30 Novartis Ag COMBINATION OF (a) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF
WO2005075454A2 (en) * 2004-02-04 2005-08-18 Novartis Ag SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE
WO2006021458A2 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040224967A1 (en) * 2003-05-02 2004-11-11 Chen Guoqing P Phenylaminopyrimidine derivatives and methods of use
US20040248918A1 (en) * 2003-05-06 2004-12-09 Il Yang Pharm. Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
WO2005058320A1 (en) * 2003-12-19 2005-06-30 Novartis Ag COMBINATION OF (a) N-{5-[4-(4-METHYL-PIPERAZINO-METHYL)-BENZOYLAMIDO]-2METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINE-AMINE AND (b) AT LEAST ONE HYPUSINATION INHIBITOR AND THE USE THEREOF
WO2005075454A2 (en) * 2004-02-04 2005-08-18 Novartis Ag SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE
WO2006021458A2 (en) * 2004-08-27 2006-03-02 Gpc Biotech Ag Pyrimidine derivatives

Also Published As

Publication number Publication date
WO2009036753A2 (de) 2009-03-26

Similar Documents

Publication Publication Date Title
WO2009068214A3 (de) Heteroaryl-substituierte piperidine
EP2054416B8 (de) Substituierte pyrazolopyrimidine, ein verfahren zu ihrer herstellung und ihre verwendung als medizin
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
ZA201001015B (en) (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
ZA201001014B (en) (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
IL203496A (en) Pharmaceutical products - improved coating, production and use
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
IL185804A0 (en) Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
WO2011056688A3 (en) Molecular profiling for personalized medicine
WO2008089397A3 (en) Adrb2 cancer markers
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
WO2008054585A3 (en) Use of pegylated il-10 to treat cancer
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
WO2010078900A3 (de) Neue aliphatisch substituierte pyrazolopyridine und ihre verwendung
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
WO2008135482A8 (de) Ionische flüssigkeiten mit polyethercarboxylaten als anionen, deren herstellung und verwendung
SG10201404159VA (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives,methods for the production thereof and use thereof for treating diseases
WO2010077589A3 (en) Stat3 inhibitors and therapeutic methods using the same
WO2009071690A3 (de) 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2009115252A3 (de) Substituierte pyrazolamide und ihre verwendung
WO2008110374A3 (de) Pellets enthaltend pharmazeutische substanz, verfahren zu deren herstellung und deren verwendung
PT1718340E (pt) Novos conjugados de efectores, processo para a sua produção e sua utilização farmacêutica
SG148120A1 (en) An oral pharmaceutical and an oral care product
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08831840

Country of ref document: EP

Kind code of ref document: A2